Search Results - "Sirhan, S."

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis by Pardanani, A, Gotlib, J, Roberts, A W, Wadleigh, M, Sirhan, S, Kawashima, J, Maltzman, J A, Shao, L, Gupta, V, Tefferi, A

Get full text

S159: QUÉBEC CML RESEARCH GROUP ANALYSIS OF TREATMENT PATTERNS IN CHRONIC MYELOGENOUS LEUKEMIA: SWITCHING IS DRIVEN BY INTOLERANCE AND SIMILAR ACROSS TYROSINE KINASE INHIBITORS AND LINES OF TREATMENT by Busque, L., Harnois, M., Szuber, N., Delage, R., Mollica, L., Olney, H., Laneuville, P., Sirhan, S., Cournoyer, G., Chamakhi, I., Lalancette, M., Talbot, D., Éthier, V., Desjardins, P., Assouline, S.

Get full text

Impact of Smoking on COVID-19 Symptoms in Non-Vaccinated Patients: A Matched Observational Study from Qatar by Haider, Mohammad Z, Al-Mannai, Amna, Al-Sirhan, Sally, Elsabagh, Ahmed, Nasser, Nasser, Al-Quraishi, Noora, Ouda, Amr, Erradi, Khadija, Ashour, Anas A, Gupta, Ishita, Abdulmajeed, Jazeel, Al-Romaihi, Hamad E, Bansal, Devendra, Musa, Omran A H, Abd Farag, Elmoubasher Abu Baker, Al-Thani, Mohammed H J, Al Moustafa, Ala-Eddin

“…Predisposition to acute illness from COVID-19 is suggested to correlate with cigarette smoking as it augments the risk of developing cardiovascular and…”
Get full text

Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia by Tefferi, Ayalew, Sirhan, Shireen, Lasho, Terra L, Schwager, Susan M, Li, Chin-Yang, Dingli, David, Wolanskyj, Alexandra P, Steensma, David P, Mesa, Ruben, Gilliland, D G

“…Polycythaemia vera (PV) is closely associated with both an acquired activating mutation of the JAK2 tyrosine kinase (JAK2(V617F)) in granulocyte-derived DNA…”
Get full text

Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group by Sirhan, Shireen, Busque, Lambert, Foltz, Lynda, Grewal, Kuljit, Hamm, Caroline, Laferriere, Nicole, Laneuville, Pierre, Leber, Brian, Liew, Elena, Olney, Harold J, Prchal, Jaroslav, Porwit, Anna, Gupta, Vikas

“…Abstract Polycythemia vera (PV) is a clonal stem cell disorder characterized by erythrocytosis and associated with burdensome symptoms, reduced quality of…”
Get full text

Red cell mass and plasma volume measurements in polycythemia : Evaluation of performance and practical utility by SIRHAN, Shireen, FAIRBANKS, Virgil F, TEFFERI, Ayalew

“…Despite the absence of any systematic evidence for diagnostic utility, red cell mass (RCM) measurement has been endorsed as a major diagnostic criterion for…”
Get full text

Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients by Arora, Brijesh, Sirhan, Shireen, Hoyer, James D., Mesa, Ruben A., Tefferi, Ayalew

“…Summary In a prospective study, peripheral blood (PB) CD34 count, bone marrow histology and other clinical parameters were concurrently evaluated in 94…”
Get full text

Safety and efficacy of CYT387, a JAK-1/2 inhibitor, for the treatment of myelofibrosis by Pardanani, A. D., Caramazza, D., George, G., Lasho, T. L., Hogan, W. J., Litzow, M. R., Begna, K., Hanson, C. A., McClure, R. F., Bavisotto, L. M., Smith, G., Kowalski, M., Sirhan, S., Roberts, A. W., Gupta, V., Gotlib, J., Tefferi, A.

“…Abstract only…”
Get full text

Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlates by Sirhan, S, Lasho, TL, Elliott, MA, Tefferi, A

“…The current study of 153 subjects with both classic and atypical myeloproliferative disorders suggests that neutrophil polycythemia rubra vera-1 (PRV-1)…”
Get full text

Distinction between processing of normal and mutant complement C3 within human skin fibroblasts by Fishelson, Zvi, Kozer, Eran, Sirhan, Saleh, Katz, Yitzhak

“…Inherited C3 deficiency may result from mutations in the C3 gene affecting transcription or translation (type I deficiency). We described a type II C3…”
Get full text